oxazepam has been researched along with Sensitivity and Specificity in 16 studies
Oxazepam: A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.
oxazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxazepam was detectable in the 5-900 ng mL(-1) range, with a detection limit of 4." | 1.34 | A rapid fluorimetric screening method for the 1,4-benzodiazepines: determination of their metabolite oxazepam in urine. ( Durand Alegría, JS; Fernández Hernando, P; Gil Tejedor, AM, 2007) |
| "Diazepam was used as the internal standard for quantitation." | 1.33 | Development and validation of a liquid chromatographic/electrospray ionization mass spectrometric method for the quantitation of prazepam and its main metabolites in human plasma. ( Atta-Politou, J; Panderi, I; Valavani, P, 2005) |
| "Temazepam was treated as the methylated metabolite of oxazepam." | 1.32 | Quantitation of drug metabolites in the absence of pure metabolite standards by high-performance liquid chromatography coupled with a chemiluminescence nitrogen detector and mass spectrometer. ( Deng, Y; Olah, TV; Wu, JT; Zhang, H, 2004) |
| "Oxazepam and diazepam was determined in serum and oxazepam in urine." | 1.29 | Determination of oxazepam and diazepam in body fluids by HPLC. ( Gajewska, M; Goldnik, A; Jaworska, M, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| Sun, J | 1 |
| Sui, X | 1 |
| Liu, J | 1 |
| Yan, Z | 1 |
| Liu, X | 1 |
| Sun, Y | 1 |
| He, Z | 1 |
| Li, J | 1 |
| Zhang, J | 1 |
| Liu, H | 1 |
| Wu, L | 1 |
| Glover, SJ | 1 |
| Allen, KR | 1 |
| Pham-Huy, C | 1 |
| Villain-Pautet, G | 1 |
| Hua, H | 1 |
| Chikhi-Chorfi, N | 1 |
| Galons, H | 1 |
| Thevenin, M | 1 |
| Claude, JR | 1 |
| Warnet, JM | 1 |
| Trapp, O | 1 |
| Trapp, G | 1 |
| Schurig, V | 1 |
| Zeng, H | 1 |
| Deng, Y | 3 |
| Wu, JT | 4 |
| Zhang, H | 1 |
| Olah, TV | 2 |
| Valavani, P | 1 |
| Atta-Politou, J | 1 |
| Panderi, I | 1 |
| Yeniceli, D | 1 |
| Dogrukol-Ak, D | 1 |
| Tuncel, M | 1 |
| Kasper, P | 1 |
| Uno, Y | 1 |
| Mauthe, R | 1 |
| Asano, N | 1 |
| Douglas, G | 1 |
| Matthews, E | 1 |
| Moore, M | 1 |
| Mueller, L | 1 |
| Nakajima, M | 1 |
| Singer, T | 1 |
| Speit, G | 1 |
| Gil Tejedor, AM | 1 |
| Fernández Hernando, P | 1 |
| Durand Alegría, JS | 1 |
| Simonsson, P | 1 |
| Lidén, A | 1 |
| Lindberg, S | 1 |
| Goldnik, A | 1 |
| Gajewska, M | 1 |
| Jaworska, M | 1 |
| Boussairi, A | 1 |
| Dupeyron, JP | 1 |
| Hernandez, B | 1 |
| Delaitre, D | 1 |
| Beugnet, L | 1 |
| Espinoza, P | 1 |
| Diamant-Berger, O | 1 |
| Lloyd, TL | 1 |
| Chi, CL | 1 |
| Unger, SE | 1 |
1 review available for oxazepam and Sensitivity and Specificity
| Article | Year |
|---|---|
Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report.
Topics: Acetamides; Animals; Carcinogens; Cyproterone Acetate; Drug Approval; Drug Industry; Follow-Up Studi | 2007 |
15 other studies available for oxazepam and Sensitivity and Specificity
| Article | Year |
|---|---|
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metab | 2009 |
A comparative study of primary secondary amino (PSA) and multi-walled carbon nanotubes (MWCNTs) as QuEChERS absorbents for the rapid determination of diazepam and its major metabolites in fish samples by high-performance liquid chromatography-electrospray
Topics: Adsorption; Animals; Chromatography, High Pressure Liquid; Diazepam; Fishes; Food Contamination; Nan | 2016 |
Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay.
Topics: Benzodiazepines; Biological Assay; Calibration; Chromatography, Liquid; European Union; Immunoassay; | 2010 |
Separation of oxazepam, lorazepam, and temazepam enantiomers by HPLC on a derivatized cyclodextrin-bonded phase: application to the determination of oxazepam in plasma.
Topics: Animals; Benzodiazepinones; Chromatography, High Pressure Liquid; Cyclodextrins; Lorazepam; Optical | 2002 |
Direct calculation and computer simulation of the enantiomerization barrier of oxazepam in dynamic HPLC experiments--a comparative study.
Topics: beta-Cyclodextrins; Chromatography, High Pressure Liquid; Computer Simulation; Cyclodextrins; Hydrog | 2002 |
Fast analysis using monolithic columns coupled with high-flow on-line extraction and electrospray mass spectrometric detection for the direct and simultaneous quantitation of multiple components in plasma.
Topics: Animals; Chromatography, High Pressure Liquid; Dogs; Fenfluramine; Oxazepam; Rats; Sensitivity and S | 2003 |
Quantitation of drug metabolites in the absence of pure metabolite standards by high-performance liquid chromatography coupled with a chemiluminescence nitrogen detector and mass spectrometer.
Topics: Animals; Chromatography, High Pressure Liquid; Dogs; Luminescent Measurements; Mass Spectrometry; Ni | 2004 |
Development and validation of a liquid chromatographic/electrospray ionization mass spectrometric method for the quantitation of prazepam and its main metabolites in human plasma.
Topics: Calibration; Chromatography, Liquid; Diazepam; Humans; Molecular Structure; Nordazepam; Oxazepam; Pr | 2005 |
Determination of leflunomide in tablets by high performance liquid chromatography.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Chemistry Techniques, Analytical; Chemistry, P | 2006 |
A rapid fluorimetric screening method for the 1,4-benzodiazepines: determination of their metabolite oxazepam in urine.
Topics: Clorazepate Dipotassium; Diazepam; Humans; Oxazepam; Sensitivity and Specificity; Spectrometry, Fluo | 2007 |
Effect of beta-glucuronidase on urinary benzodiazepine concentrations determined by fluorescence polarization immunoassay.
Topics: Benzodiazepines; Chromatography, High Pressure Liquid; Fluorescence Polarization Immunoassay; Glucur | 1995 |
Determination of oxazepam and diazepam in body fluids by HPLC.
Topics: Chromatography, High Pressure Liquid; Clonazepam; Diazepam; Humans; Oxazepam; Regression Analysis; R | 1993 |
Urine benzodiazepines screening of involuntarily drugged and robbed or raped patients.
Topics: Adolescent; Adult; Benzodiazepines; False Negative Reactions; Female; Humans; Illicit Drugs; Immunoe | 1996 |
The development of a staggered parallel separation liquid chromatography/tandem mass spectrometry system with on-line extraction for high-throughout screening of drug candidates in biological fluids.
Topics: Chromatography, Liquid; Drug Evaluation, Preclinical; Drugs, Investigational; Humans; Mass Spectrome | 2001 |
High-speed gradient parallel liquid chromatography/tandem mass spectrometry with fully automated sample preparation for bioanalysis: 30 seconds per sample from plasma.
Topics: Animals; Automation; Blood Chemical Analysis; Chromatography, Liquid; Dogs; Humans; Mass Spectrometr | 2002 |